Avanos Recalls Ballard Closed Suction Systems

Due to sterilization failure

May result in non-sterile devices

Avanos Medical, Inc. is recalling its Ballard Closed Suction Systems after identifying a failure in the sterilization process, which may result in non-sterile devices. Use of these products could lead to serious health risks, including infection, airway injury, inflammation, sepsis, or death.

No injuries or deaths have been reported to date.

About the Device

The Ballard Closed Suction System is used for removing airway secretions in ventilated patients, helping to maintain ventilation without disconnecting the circuit — a critical function in respiratory care.

Recommended Actions (as of March 19, 2025)

  • Immediately stop using any affected products and quarantine them.
  • Check your inventory for affected items listed in the recall notice.
  • Notify any customers or departments you may have shared the product with.
  • Complete and return the Response Form to: productquality@myairlife.com.
  • Arrange for return or confirm destruction of affected units to receive replacements.
  • Communicate the recall to all relevant staff within your organization.
  • For urgent replacement needs, contact AirLife at 1-800-433-2797.

Need Help?

For questions or support related to the recall, contact Avanos Medical, Inc. at 1-800-433-2797.

Healthcare providers are urged to act promptly to prevent potential harm to patients relying on these critical airway management systems.

Affected Products

Affected Product

Product Names:

  • Ballard Closed Suction System for Neonates/Pediatrics, 8 F, Y-Adapter
  • Ballard Closed Suction System for Neonates/Pediatrics, 10 F, Elbow 
  • Ballard Closed Suction System for Neonates/Pediatrics, 8 F, Elbow
  • Ballard Closed Suction System for Adults, 14 F, T-Piece 
  • Ballard Closed Suction System for Adults, 14 F, DSE
  • Ballard Turbo-Cleaning Closed Suction System for Adults, 14 F, DSE, MDI 
  • Ballard Turbo-Cleaning Closed Suction System for Adults, 14 F, DSE

Click here to see a full list of affected devices.

News

FDA Enforcement

Safety Alerts

Medical Devices

Pharma

New Drugs

Drug Shortages

FDA Approval for Cancer Treatment Aid

The Food and Drug Administration (FDA) on 12 December 2022 announced the approval of Agilent's Resolution CTDX FIRST, a new in vitro diagnostic (IVD) medical device for use in the detecting a specific mutation in the KRAS gene in circulating cell-free DNA. This test...

FDA Posts Warning Letter to MicroVention Costa Rica 

Identifies several violations of the FD&C Act and QSR  On February 7, FDA issued a warning letter it had sent to MicroVention Costa Rica SRL on September 30, 2022. The company is a subsidiary of MicroVention Inc., a medical device company based in Tustin,...

FDA Issues Letter to Warn of Abbott Trifecta Valve Risks 

Letter outlines risks associated with the heart valve  On February 27, the FDA released a letter to healthcare providers concerning potential risks associated with Abbott Trifecta valves. The Trifecta valve is a type of heart valve that is implanted in patients during...